Share Name Share Symbol Market Type Share ISIN Share Description
Surgical Innov. LSE:SUN London Ordinary Share GB0004016704 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 3.775p 3.65p 3.90p 3.775p 3.775p 3.775p 241,467 07:53:39
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 6.1 0.3 0.2 25.2 20.14

Surgical Innovations Share Discussion Threads

Showing 10151 to 10175 of 10175 messages
Chat Pages: 407  406  405  404  403  402  401  400  399  398  397  396  Older
DateSubjectAuthorDiscuss
26/7/2017
12:54
Assume interims will be end August. Have to think that the statement will be positive-therefore buy the shares ahead? Or is there a flaw in my reasoning! Great posts buywell as before -almost re-energised myself to do more research here. The SUN share price should be capable of once again getting back into double figures if things go to plan.
meijiman
24/7/2017
12:13
I have added a couple of more thoughts to my previous post ................... Can AMS make the SUN shine for Surgical Innovations ? ............................ Back in 2011 SUN did a deal with AMS to develop a new unique surgical instrument to apply glue in very controlled 'drops' for operations using a mesh , targeted for hernia operations It later was called 'LiquiBand® Fix 8™' by AMS after SUN designed and manufactured it and it was approved ( remember the approved word) Here is the announcement hTTps://www.admedsol.com/investor-relations/regulatory-news-announcements/751862-912/ Agreement with Surgical Innovations Group RNS Number : 3798N Advanced Medical Solutions Grp PLC 01 September 2011  Development and Pre-Supply Agreement signed with Surgical Innovations Group plc Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, today announces that it has signed a Development and Pre-Supply Agreement (“the Agreement”) with Surgical Innovations Group plc (“Surgical Innovations”) (AIM: SUN), for the development and supply of a novel device for internal application of adhesives and sealants. Under the terms of the Agreement, Surgical Innovations will develop and retain the intellectual property rights for a unique applicator to deliver accurately, individual drops of adhesive or sealant internally within the body, accessed via a minimally invasive surgical port site. In return for the exclusive rights to this applicator for the internal application of adhesives and sealants, AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years. The development of the internal applicator is a key step in extending the Company’s expertise in adhesives and sealants from purely topical applications to also addressing clinical needs inside the body. AMS has previously highlighted that the first target internal application would be the hernia mesh fixation market which is currently served by sutures, staples and tacks. This new internal applicator, together with the Company’s adhesives, will allow AMS to address this important market with reduced surgical complications. Commenting on this announcement, Chris Meredith, Chief Executive Officer of AMS said: “This agreement combines our formulation and regulatory expertise with Surgical Innovations’ applicator design and manufacturing expertise to introduce a new product to a global market for internal sealants that is now in excess of US$600 million. As we have previously indicated, an integral part of our tissue sealant and adhesives R&D is focused on moving our product range more towards the Operating Room, including internal applications. In this regard, we are optimistic that our partnership with Surgical Innovations will give us a market leading product, targeting the hernia mesh fixation market, which should be available for launch in 2013.” Graham Bowland, Chief Executive Office of Surgical Innovations added: “Our agreement with AMS affirms SI’s reputation in delivering leading design solutions to OEM customers. The applicator device for AMS is a natural extension to our existing minimally invasive surgical product portfolio and we have already commenced on the design work on a fully disposable device. As part of the agreement SI will retain the full intellectual property rights to the applicator device and will also manufacture it on behalf of AMS.” A LANDMARK DEAL IMO Before I go on let us explore a few of the words and phrases used in the above that IMO are KEY to the future of both SUN and AMS as the use of medical grade glue takes off in the USA and Globally for internal and external operations and medical use. 1) Even when this deal was hatched AMS were seeing that there could be various uses for the device that they wanted SUN to design ,get approval for and then manufacture. Note: ''addressing clinical needs inside the body. AMS has previously highlighted that the first target internal application would be the hernia mesh fixation market '' plural ''needs'' and the word ''first'' also '' an integral part of our tissue sealant and adhesives R&D is focused on moving our product range more towards the Operating Room, including internal applications.'' plural ''applications'' 2) Another thing that is very important about the deal for SUN is that they get to OWN THE IP This means that in 2024 when the 10 year deal is up , SUN own the IP to the device that by then AMS should be using in the USA and in many other countries across the world. One thing the old SUN CEO did right was signing this deal I get a bit forward with my thoughts so let us carry on with what transpired SUN got to work and it took some time to get approval but it came on 30th May 2014 hTTps://www.investegate.co.uk/surgical-innovations/rns/ce-approval-for-hernia-mesh-fixation-device/201405300700134114I/ The 10 year clock started when the device was 'approved' SUN would now start to manufacture LiquiBand® Fix 8™ and under the agreement ' AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.' ie till 30th May 2024 So how is this LiquiBand® Fix 8™ going for AMS ? ......... not bad it would seem From the Advanced Medical Solutions Group PLC Unaudited preliminary results MARCH 14, 2017 ''Sales of the hernia mesh fixation device, LiquiBand® Fix8™ increased 73% to £1.7 million (2016: £1.0 million), 68% at constant currency, and is in use in 25 countries; now preparing for Pre Market Approval (PMA) in US'' hTTps://markets.ft.com/data/announce/detail?dockey=1323-13157130-3LNBK6AU6KJ6UI22FAN6KPA87C&mhq5j=e3 Now you will notice this 73% increase was WITHOUT the USA using LiquiBand® Fix8™, they can't because it was not approved for use in the USA on March 14 2017 But it is in use in 25 countries And SUN is manufacturing all of the LiquiBand® Fix8™ devices as per the 10 year deal Is this LiquiBand® Fix8™ going to be a winner for SUN as well as for AMS ? IMO the USA will at least match the ROW sales of LiquiBand® Fix8™ within 12 months of it getting USA approval ie the market will be worth DOUBLE what it was for Hernia operations ie £3.4M Can LiquiBand® Fix8™ do better ? Well that depends if it can be used for other types of operations than just Hernia , can it ? First the instrument and the op ..... not for the sqeemish hTTps://www.youtube.com/watch?v=IAC8Hfg0WNU Do we need other uses ? Hernia Mesh Devices Market worth $3.73 Billion USD by 2020 ''The global hernia mesh devices market report defines and segments the concerned market in four regions with analysis and forecast of revenue. The global hernia mesh devices market is estimated to grow at a CAGR of 2.0%, from 2015 to 2020, to reach a market size of USD 3.73 Billion by 2020. Rising awareness levels, increasing aging population, and sedentary lifestyle are the major factors influencing the growth of the market.'' hTTp://www.marketsandmarkets.com/PressReleases/hernia-mesh-devices.asp And whilst I expect existing sales to double when the USA gives approval, from the above link look at Asia Pacific region (APAC) .... looks like a huge sales opportunity coming ''APAC has a large population, it benefits in terms of a huge patient pool. In 2014, around 62% of total number of hernia repair procedures performed worldwide were in APAC, which shows huge potential of this region. Presently, around only 50% of these patient goes for hernia repair using mesh, but in future this percent will increase due to increasing awareness regarding invasive hernia repairing which may result in infection, bleeding, and increased duration of hospitalization. In cases where mesh is used, surgery is minimally invasive and less painful. Using mesh to treat hernia reduces risk of reoccurrence of hernia. Due to these factors, APAC hernia mesh market is expected to grow at the highest CAGR from 2015 to 2020'' So what does this mean for SUN regarding the growth of LiquiBand® Fix8™ sales ? ....................... AMS reported in their March 2016 results '' Hernia mesh fixation device, LiquiBand® Fix8™, delivered £1.0m of sales in the first full year and launched in 20 countries '' AMS reported in their March 2017 results '' Sales of the hernia mesh fixation device, LiquiBand® Fix8™ increased 73% to £1.7 million (2016: £1.0 million), 68% at constant currency, and is in use in 25 countries; now preparing for Pre Market Approval (PMA) in US'' There are enough countries in the world for AMS to add 5 more for the next 7 years to 2024 An increase in sales growth for LiquiBand® Fix8™of 50% a year over the next 5 years does not seem to be demanding as they achieved 73% last year and are starting from a low base V established competitors in the hernia operations MIS market.(Minimal Invasive Surgery) Therefore from sales of £1.7M 50% would give £2.55M in 2018 From sales of £2.55M in 2018 50% would give £3.82M in 2019 From sales of 3.82M in 2019 50% would give £5.73M in 2020 From sales of £5.73M in 2020 50% would give £8.59M in 2021 Note: The numbers in2020 and 2021 above would be LOW as the device should get approval in 2019, FDA approval is underway and takes about 3 years, so in 2020 and 2021 LiquiBand® Fix8™ would now have USA FDA approval and be achieving considerable sales there (it might even get released late 2019) Thus IMO the sales number above of 8.59M with 2020 and,2021 sales added could be another £4.5M giving around £13M in 2022 ( see later comments re other uses for LiquiBand® Fix8™, this could be on the low side) £13M sales in 2022 of LiquiBand® Fix8™ .... unlucky number ? Not for SUN though as they probably get nearly half of that money as the LiquiBand® Fix8™ kit consists of the SUN LiquiBand® Fix8™ device itself plus the piece of mesh ( say £20 ) plus the tube of glue (say £20) BUT .... there is a good chance IMO that more is to come from LiquiBand® Fix8™ If you watch the Hernia mesh operation using LiquiBand® Fix8™ you will see 3 interesting things 1. The LiquiBand® Fix8™ can be used (and is being/has been used) to also repair the peritoneum so it can have additional uses for other operations now. Here is the video clip, audio comes at the end hTTps://www.youtube.com/watch?v=LycfAqZXclM 2. And you can also see that MIS graspers are also used in the Hernia operation ? SUN makes those Will or perhaps are , AMS also offering a complete package to clients ie with or without graspers made by SUN? .... let us hope they are. 3. If you know your MIS equipment you will also see that a Port Access device is used in the operation SUN makes those also AND has recently stated it is going to add more products to its Port Access range In the March 2017 results SUN said .............. and (OEM is Operating Emergency Room) ''Brand identity, innovation and global reach The SI Brand was further enhanced in the year by the much-anticipated launch of the Yelloport™ Elite range, a new port access system utilising universal seal technology giving significantly improved performance for surgeons and theatre staff. The Group remains focused on innovation and development of its portfolio of products, brand recognition and the identification of as yet unmet clinical needs in order to drive the product roadmap effectively.'' and ''The Group continues to work closely with strategic partnerships on OEM projects which challenge our Design and Development teams and complement the core competencies that the Group demonstrates. The greater emphasis placed on new product introduction culminated in the launch of the Yelloport ™ Elite range in the final quarter of 2016, this will be followed by further additions to this range in Q2 2017 as well as two more projects launching before the end of H1. The Group is excited to be able to offer these products to the market and remains committed to expanding the portfolio of products available further in 2017 and beyond. '' Makes me wonder who might be going to use SUN new YellowPort Elite OEM products ? Could they form part of a complete new AMS Hernia LiquiBand® Fix8™Operations Package ? This would then be SUN MIS Graspers , SUN YellowPort access device and the LiquiBand® Fix 8™ device and kit. (Remember the SUN designed,exclusively manufactured for AMS by SUN Surgical Glue Instrument is the hub and main item for the application of the mesh in the operation) There have been a couple of minor mods to the SUN Instrument involving the tip and the way the instrument primes before use ..... these have been done after listening to surgeons feedback and were done some time ago. Surgeons that use it like it .... which is why sales are on the up .... and surgeons have discovered other uses for themselves which are now being addressed. For SUN more uses for LiquiBand® Fix 8™ would be good so .... More uses Chris Meredith, Chief Executive Officer of AMS, commented: "LiquiBand® Fix 8™ is an important product for AMS and demonstrates our innovation and market agility. We are delighted with the response we have received following the launch from surgeons who have been extremely positive about the ease of use of this device and the benefit it brings to patients, reducing the pain that can be experienced when tacks or staples are used. This is the first extension of the claims of LiquiBand® Fix 8™ and we expect to develop further opportunities for this kind of application, broadening the market for the use of adhesives internally. This is an important part of our strategy to increase our penetration of the Operating Theatre segment of the wound closure market." Latest news Advanced Medical Solutions Group 14 Mar 2017 07:00:13 ''Research and Development In R&D our focus is on continuing to improve the formulations of the base monomers that are used in our adhesives as well as improving the design and innovation around our devices. We have modified the tip and priming mechanism of our hernia fixation device following surgeon feedback and have started the process to get FDA approval to sell this product into the US. Development work has also started on an open hernia mesh fixation device which we hope will gain approval in Europe this year. In addition, work has begun on gaining approval in Europe for the LiquiBand® Fix 8™ device for new indications and it is expected we will be selling the first of these in 2018.'' So there we have it The CEO of AMS has recently stated : ''work has begun on gaining approval in Europe for the LiquiBand® Fix 8™ device for new indications and it is expected we will be selling the first of these in 2018.'' Looks like more work for SUN to me, and don't forget hTTps://www.investegate.co.uk/surgical-innovations/rns/ce-approval-for-hernia-mesh-fixation-device/201405300700134114I/ The 10 year clock started when the device was 'approved' SUN would now start to manufacture LiquiBand® Fix 8™ and under the agreement ' AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.' ie till 30th May 2024 What will AMS do after 30th May 2024 ? Because as part of the deal , SUN owns the IP .... they can then license or sell it to another company. By then IMO it could be a major earner for AMS enabling increasing sales of its medical grade glue for use in various OEM internal operations. dyor
buywell3
24/7/2017
10:22
Bit of a buying spell atm, always welcome ;)
gbh2
24/7/2017
07:57
buywell - thanks for that.
lurki0
23/7/2017
15:53
What a nice bloke ..... I assume you meant my AMS epic which I shall add again in the morning for any advfn newbes that are too lazy to scroll through an hours worth of posts. Lurki0 I am pleased to see you here as I see you are indeed quite a rare poster I find it quite interesting that Elemental Healthcare are still showing SUN products on their website , as the 5yrs was up 31st May 2017 and my reading of the deal was that SUN got the £5M for the granting of exclusive 5yrs UK rights for all SUN products ie £1M a year. My reading of the agreement also was that Elemental Healthcare would also accept/take an agreed amount of SUN products per year. Here is the link hTTp://www.elementalhealthcare.co.uk/index.php/our-products/mis/#.WXS3whXyvIU So it would seem they are still selling SUN products in the UK unless the website has not been updated If so are SUN still getting around £1M a year as part of another 5yr agreement ? Here is the old deal again Surgical Innovations Group plc 31 May 2012 UK distribution agreement with Elemental Healthcare Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces that it has signed a five year extension to its distribution agreement with UK distributor Elemental Healthcare Ltd ('Elemental'). The agreement, which is based on minimum contracted volumes, will be worth £5m over the five years and provides Elemental with continued exclusive distribution rights to SI's entire product portfolio within Great Britain under the SI brand. The extension marks the continuation of a relationship that began in 2007 and provides the Board with confidence for the full year. Over this time SI has established strong links between Elemental and its design team and Clinical Advisory Board to identify the surgical needs for new innovative technologies and update its existing product portfolio. Graham Bowland, Chief Executive Officer of SI, said: "We are very pleased to reinforce our relationship with Elemental and Great Britain is an important market for us where our Resposable® products offer the NHS significant costs savings over expensive disposable instruments. According to a study carried out by Elemental into the use of our YelloPort+plus™ products, hospitals that switched from disposable to Resposable® saved over £100,000 over 500 procedures as well as producing less clinical waste." Adam Power, Managing Director of Elemental, said: "As a leading distributor of solutions for minimally invasive surgery we are delighted to extend our agreement with SI, whose innovative products reduce the overall cost of surgical intervention; a key driver in the UK market."
buywell3
23/7/2017
11:22
I believe a number of things were put on hold a couple of years ago when the company's position looked frankly quite perilous. Now things have stabilised I believe SUN management are on the front foot once again and may be able to revisit and develop some of these areas. Brilliant post Buywell.
meijiman
23/7/2017
11:03
Nice digging, buywell. I wasn't aware that this was so. Presumably the implication is that SUN now have a freer hand to strike new (and one hopes more profitable)deals for the distribution of the core products?
lurki0
23/7/2017
05:41
SUN had a 5yr deal with Elemental Healthcare worth £5M The 5 years were UP on 31st May 2017  Surgical Innovations Group plc 31 May 2012 UK distribution agreement with Elemental Healthcare Surgical Innovations Group plc (AIM: SUN), the designer and manufacturer of creative solutions for minimally invasive surgery ('MIS'), announces that it has signed a five year extension to its distribution agreement with UK distributor Elemental Healthcare Ltd ('Elemental'). The agreement, which is based on minimum contracted volumes, will be worth £5m over the five years and provides Elemental with continued exclusive distribution rights to SI's entire product portfolio within Great Britain under the SI brand. The extension marks the continuation of a relationship that began in 2007 and provides the Board with confidence for the full year. Over this time SI has established strong links between Elemental and its design team and Clinical Advisory Board to identify the surgical needs for new innovative technologies and update its existing product portfolio. Graham Bowland, Chief Executive Officer of SI, said: "We are very pleased to reinforce our relationship with Elemental and Great Britain is an important market for us where our Resposable® products offer the NHS significant costs savings over expensive disposable instruments. According to a study carried out by Elemental into the use of our YelloPort+plus™; products, hospitals that switched from disposable to Resposable® saved over £100,000 over 500 procedures as well as producing less clinical waste." Adam Power, Managing Director of Elemental, said: "As a leading distributor of solutions for minimally invasive surgery we are delighted to extend our agreement with SI, whose innovative products reduce the overall cost of surgical intervention; a key driver in the UK market."
buywell3
22/7/2017
17:53
Thanks Lurki0 I hope you agreed with my thoughts , I think that it was the 10 year deal with Advanced Medical Solutions that has 1. Interested Chris Rea when he became involved 2. Interested Nigel Rogers when he became the Chairman 3. Interests me and I think a few more I know SUN are looking at adding/broadening their range of products , and have done so and are doing more. But I find it very comforting to think that SUN is quietly manufacturing an ever increasing number of LiquiBand® Fix 8™ units for AMS A nice base to keep building up from till 2024 and beyond SUN should have acquired at least 2 or 3 more companies by then IMO assuming of course : It has not been acquired itself in the meantime PS: Next week I will do a post about the SUN chart as it is getting to a very interesting point itself.
buywell3
22/7/2017
15:30
Buywell - a very interesting read, most informative. I re-loaded last week so your piece was very timely.
lurki0
22/7/2017
13:41
Glad you liked it ..... but I did not say who AMS is I made an assumption which was wrong of me AMS for those that do not know is Advanced Medical Solutions They have a MkT Cap of nearly £700 Million hTTps://markets.ft.com/data/equities/tearsheet/summary?s=AMS:LSE Whilst the youtube videos of the operations are a bit grizzly , if you can I urge you to watch as you can see the other products being used as well as the Surgical Innovations manufactured and designed LiquiBand® Fix 8™ medical grade glue Minimal Invasive Surgical Instrument. MIS is the way hospitals are going to get patients in and out ASAP , which avoids bed use, allowing more patients through the doors and cuts down on the time that hospital acquired infections can kick in thus saving the NHS many hundreds of £Millions in legal payouts ..... as well as getting the job done better and quicker ( less time under anaesthetic) which means less stress and less chance of complications.
buywell3
22/7/2017
11:16
cracking read - thanks
mandate
22/7/2017
09:18
.............................. Can AMS make the SUN shine for Surgical Innovations ? ............................ Back in 2011 SUN did a deal with AMS to develop a new unique surgical instrument to apply glue in very controlled 'drops' for operations using a mesh , targeted for hernia operations It later was called 'LiquiBand® Fix 8™' by AMS after SUN designed and manufactured it and it was approved ( remember the approved word) Here is the announcement hTTps://www.admedsol.com/investor-relations/regulatory-news-announcements/751862-912/ SUN got to work and it took some time to get approval but it came on 30th May 2014 hTTps://www.investegate.co.uk/surgical-innovations/rns/ce-approval-for-hernia-mesh-fixation-device/201405300700134114I/ The 10 year clock started when the device was 'approved' SUN would now start to manufacture LiquiBand® Fix 8™ and under the agreement ' AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.' ie till 30th May 2024 So how is this LiquiBand® Fix 8™ going for AMS ? ......... not bad it would seem From the Advanced Medical Solutions Group PLC Unaudited preliminary results MARCH 14, 2017 ''Sales of the hernia mesh fixation device, LiquiBand® Fix8™ increased 73% to £1.7 million (2016: £1.0 million), 68% at constant currency, and is in use in 25 countries; now preparing for Pre Market Approval (PMA) in US'' hTTps://markets.ft.com/data/announce/detail?dockey=1323-13157130-3LNBK6AU6KJ6UI22FAN6KPA87C&mhq5j=e3 Now you will notice this 73% increase was WITHOUT the USA using LiquiBand® Fix8™, they can't because it was not approved for use in the USA on March 14 2017 But it is in use in 25 countries And SUN is manufacturing all of the LiquiBand® Fix8™ devices as per the 10 year deal Is this LiquiBand® Fix8™ going to be a winner for SUN as well as for AMS ? IMO the USA will at least match the ROW sales of LiquiBand® Fix8™ within 12 months of it getting USA approval ie the market will be worth DOUBLE what it was for Hernia operations ie £3.4M Can LiquiBand® Fix8™ do better ? Well that depends if it can be used for other types of operations than just Hernia , can it ? First the instrument and the op ..... not for the sqeemish hTTps://www.youtube.com/watch?v=IAC8Hfg0WNU Do we need other uses ? Hernia Mesh Devices Market worth $3.73 Billion USD by 2020 ''The global hernia mesh devices market report defines and segments the concerned market in four regions with analysis and forecast of revenue. The global hernia mesh devices market is estimated to grow at a CAGR of 2.0%, from 2015 to 2020, to reach a market size of USD 3.73 Billion by 2020. Rising awareness levels, increasing aging population, and sedentary lifestyle are the major factors influencing the growth of the market.'' hTTp://www.marketsandmarkets.com/PressReleases/hernia-mesh-devices.asp And whilst I expect existing sales to double when the USA gives approval, from the above link look at Asia Pacific region (APAC) .... looks like a huge sales opportunity coming ''APAC has a large population, it benefits in terms of a huge patient pool. In 2014, around 62% of total number of hernia repair procedures performed worldwide were in APAC, which shows huge potential of this region. Presently, around only 50% of these patient goes for hernia repair using mesh, but in future this percent will increase due to increasing awareness regarding invasive hernia repairing which may result in infection, bleeding, and increased duration of hospitalization. In cases where mesh is used, surgery is minimally invasive and less painful. Using mesh to treat hernia reduces risk of reoccurrence of hernia. Due to these factors, APAC hernia mesh market is expected to grow at the highest CAGR from 2015 to 2020'' So what does this mean for SUN regarding the growth of LiquiBand® Fix8™ sales ? ....................... AMS reported in their March 2016 results '' Hernia mesh fixation device, LiquiBand® Fix8™, delivered £1.0m of sales in the first full year and launched in 20 countries '' AMS reported in their March 2017 results '' Sales of the hernia mesh fixation device, LiquiBand® Fix8™ increased 73% to £1.7 million (2016: £1.0 million), 68% at constant currency, and is in use in 25 countries; now preparing for Pre Market Approval (PMA) in US'' There are enough countries in the world for AMS to add 5 more for the next 7 years to 2024 An increase in sales growth for LiquiBand® Fix8™of 50% a year over the next 5 years does not seem to be demanding as they achieved 73% last year and are starting from a low base V established competitors in the hernia operations MIS market.(Minimal Invasive Surgery) Therefore from sales of £1.7M 50% would give £2.55M in 2018 From sales of £2.55M in 2018 50% would give £3.82M in 2019 From sales of 3.82M in 2019 50% would give £5.73M in 2020 From sales of £5.73M in 2020 50% would give £8.59M in 2021 Note: The numbers in2020 and 2021 above would be LOW as the device should get approval in 2019, FDA approval is underway and takes about 3 years, so in 2020 and 2021 LiquiBand® Fix8™ would now have USA FDA approval and be achieving considerable sales there (it might even get released late 2019) Thus IMO the sales number above of 8.59M with 2020 and,2021 sales added could be another £4.5M giving around £13M in 2022 ( see later comments re other uses for LiquiBand® Fix8™, this could be on the low side) £13M sales in 2022 of LiquiBand® Fix8™ .... unlucky number ? Not for SUN though as they probably get nearly half of that money as the LiquiBand® Fix8™ kit consists of the SUN LiquiBand® Fix8™ device itself plus the piece of mesh ( say £20 ) plus the tube of glue (say £20) BUT .... there is a good chance IMO that more is to come from LiquiBand® Fix8™ If you watch the Hernia mesh operation using LiquiBand® Fix8™ you will see 3 interesting things 1. The LiquiBand® Fix8™ can be used (and is being/has been used) to also repair the peritoneum so it can have additional uses for other operations now. Here is the video clip, audio comes at the end hTTps://www.youtube.com/watch?v=LycfAqZXclM 2. And you can also see that MIS graspers are also used in the Hernia operation ? SUN makes those Will or perhaps are , AMS also offering a complete package to clients ie with or without graspers made by SUN? .... let us hope they are. 3. If you know your MIS equipment you will also see that a Port Access device is used in the operation SUN makes those also AND has recently stated it is going to add more products to its Port Access range In the March 2017 results SUN said .............. and (OEM is Operating Emergency Room) ''Brand identity, innovation and global reach The SI Brand was further enhanced in the year by the much-anticipated launch of the Yelloport™ Elite range, a new port access system utilising universal seal technology giving significantly improved performance for surgeons and theatre staff. The Group remains focused on innovation and development of its portfolio of products, brand recognition and the identification of as yet unmet clinical needs in order to drive the product roadmap effectively.'' and ''The Group continues to work closely with strategic partnerships on OEM projects which challenge our Design and Development teams and complement the core competencies that the Group demonstrates. The greater emphasis placed on new product introduction culminated in the launch of the Yelloport ™ Elite range in the final quarter of 2016, this will be followed by further additions to this range in Q2 2017 as well as two more projects launching before the end of H1. The Group is excited to be able to offer these products to the market and remains committed to expanding the portfolio of products available further in 2017 and beyond. '' Makes me wonder who might be going to use SUN new YellowPort Elite OEM products ? Could they form part of a complete new AMS Hernia LiquiBand® Fix8™Operations Package ? This would then be SUN MIS Graspers , SUN YellowPort access device and the LiquiBand® Fix 8™ device and kit. (Remember the SUN designed,exclusively manufactured for AMS by SUN Surgical Glue Instrument is the hub and main item for the application of the mesh in the operation) There have been a couple of minor mods to the SUN Instrument involving the tip and the way the instrument primes before use ..... these have been done after listening to surgeons feedback and were done some time ago. Surgeons that use it like it .... which is why sales are on the up .... and surgeons have discovered other uses for themselves which are now being addressed. For SUN more uses for LiquiBand® Fix 8™ would be good so .... More uses Chris Meredith, Chief Executive Officer of AMS, commented: "LiquiBand® Fix 8™ is an important product for AMS and demonstrates our innovation and market agility. We are delighted with the response we have received following the launch from surgeons who have been extremely positive about the ease of use of this device and the benefit it brings to patients, reducing the pain that can be experienced when tacks or staples are used. This is the first extension of the claims of LiquiBand® Fix 8™ and we expect to develop further opportunities for this kind of application, broadening the market for the use of adhesives internally. This is an important part of our strategy to increase our penetration of the Operating Theatre segment of the wound closure market." Latest news Advanced Medical Solutions Group 14 Mar 2017 07:00:13 ''Research and Development In R&D our focus is on continuing to improve the formulations of the base monomers that are used in our adhesives as well as improving the design and innovation around our devices. We have modified the tip and priming mechanism of our hernia fixation device following surgeon feedback and have started the process to get FDA approval to sell this product into the US. Development work has also started on an open hernia mesh fixation device which we hope will gain approval in Europe this year. In addition, work has begun on gaining approval in Europe for the LiquiBand® Fix 8™ device for new indications and it is expected we will be selling the first of these in 2018.'' So there we have it The CEO of AMS has recently stated : ''work has begun on gaining approval in Europe for the LiquiBand® Fix 8™ device for new indications and it is expected we will be selling the first of these in 2018.'' Looks like more work for SUN to me, and don't forget hTTps://www.investegate.co.uk/surgical-innovations/rns/ce-approval-for-hernia-mesh-fixation-device/201405300700134114I/ The 10 year clock started when the device was 'approved' SUN would now start to manufacture LiquiBand® Fix 8™ and under the agreement ' AMS has agreed to purchase all of its requirements for the approved new applicator from Surgical Innovations for a period of ten years.' ie till 30th May 2024 dyor
buywell3
21/7/2017
17:18
My buy earlier this week also showed as a sell. I like the new distribution areas to bring new products into. Cash generation attractive and trend is your friend.
lanzarote666
21/7/2017
16:41
1.4M shares traded today , more than yesterday Latest trades Time Price Volume Value 16:16:19 3.76052 200,000 7,521 16:16:03 3.84 200,000 7,680 15:54:18 3.84 4,000 154 14:57:50 3.75 250,000 9,375 14:30:27 3.788 60,000 2,273 14:02:47 3.75 200,000 7,500 14:01:56 3.84 200,000 7,680 13:57:39 3.789 200,000 7,578 12:35:59 3.79 26,174 992 09:05:04 3.8 5,065 192 08:15:30 3.7 50,000 1,850 08:00:44 3.7 48,344 1,789
buywell3
21/7/2017
16:12
The games that MM's play I have nearly completed my story about SUN and AMS .... it is turning into an epic I have even got myself excited .... which takes some doing
buywell3
21/7/2017
14:36
If anyone is interested , the 60000 trade at 3.788 shown as a 'sell' was actually me topping up my holding. We can assume therefore that the earlier trades of 200,000 each at about the same price today were also'buys' Good to see I'm not the only one at last optimistic about prospects for the future.
kenone
20/7/2017
19:55
You know how these MM's work , sometimes they work a trade in later in the day , even after 18.00 hrs I am not kidding. Sometimes the trades don't get reported at all .... again I am not kidding Not saying re SUN , but it does happen. I would say it was an early buy I have just been working on a post re SUN and AMS which I shall post soon when I get it finished. It will make good reading I can assure you dyor
buywell3
20/7/2017
18:23
550k trade a buy or sell?
jmf69
20/7/2017
18:11
Over 1.25 Million shares traded today .... with a nice 550,000 thrown in perhaps some news soon ? Latest trades Time .. .Price Volume Value 16:33:03 3.75 550,000 20,625 15:28:50 3.701 150,000 5,552 15:21:57 3.85 21,926 844 13:32:58 3.85 137,267 5,285 11:49:09 3.85 50,000 1,925 11:39:47 3.85 65,000 2,503 10:31:45 3.8 26,080 991 10:25:04 3.8 25,000 950 10:14:28 3.8 26,106 992 10:09:10 3.75 49,473 1,855 09:54:30 3.749 15,000 562 08:45:12 3.75 150,000 5,625
buywell3
20/7/2017
15:55
Good luck with your picks Small Caps like SUN with a good experienced leader with a good track record are hard to find like you say. The chart of SUN is shaping up very well indeed Good news will lift it from here without too much effort I like charts Check out SDI
buywell3
20/7/2017
10:51
Buywell3 Tks,Since very early March, long term hold, this is not a trading stock really. Doubt any launches before the autumn but happy to hold, investors are definitely trawling the markets for little gems, hopefully this will be one of them in time! Also in WEY, IGE,VLS, KMK for the same reasons. GL
ny boy
20/7/2017
10:26
Have you been in this one long NY Boy ? Ah for a while NY Boy - 10 Mar 2017 - 12:57:24 - 4029 of 4129 (Surging) Surgical Innovations - SUN Buying ahead of the results next Tuesday, holding these long term. I see you get around a bit ..... blimey ....prolific ....... I thought I posted a lot I reckon you are ahead of me .... well done , hope you do well with SUN also Hoping we read more products announced for AMS soon
buywell3
20/7/2017
10:24
Resistance 4.0p Support. 3.4p
ny boy
20/7/2017
10:23
Long term chart is still good and in a uptrend. Buy on weakness imho Patience required until it finally powers north for a breakout on heavy vols.
ny boy
Chat Pages: 407  406  405  404  403  402  401  400  399  398  397  396  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:42 V: D:20170726 20:43:03